105 results
Page 3 of 6
424B5
9kct7oqn moejc
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
vbbvvng24244n14x
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-99.1
z2bq 6qrc
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
8bget61ncwrya1
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
424B3
3gb3hvsut9j92o3b7b7
30 Apr 21
Prospectus supplement
5:01pm
8-K/A
EX-99.1
2nk1w9dqwuz045e9r08
5 Mar 21
Financial Statements and Exhibits
4:15pm
8-K/A
EX-99.3
uscj8y4 9u6j
5 Mar 21
Financial Statements and Exhibits
4:15pm
8-K
EX-10.1
b4qv4zp7ctf8
1 Feb 21
Departure of Directors or Certain Officers
6:55am